| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-02 | FY 2024
FILED 2025-05-03 | FY 2023
FILED 2024-04-27 |
|---|---|---|---|
| Revenue (Total Sales) | $1.02B | $1.05B | $1.11B |
| YoY Revenue Growth % | -2.8% | -6.0% | — |
| Gross Profit | $202.2M | $163.4M | — |
| Gross Margin % | 19.8% | 15.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $8.8M | -$23.9M | -$112.0M |
| Operating Margin % | 0.9% | -2.3% | -10.0% |
| Net Income (GAAP) | -$35.7M | -$62.6M | -$123.3M |
| EBITDA (Normalized) | $26.7M | $9.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $38.0M | $26.4M | $47.5M |
| Capital Expenditures (CapEx) | $22.4M | $41.6M | — |
| Free Cash Flow (FCF) | $15.6M | -$15.2M | $47.5M |
| FCF Margin % | 1.5% | -1.5% | 4.3% |
| Return on Invested Capital (ROIC %) | 0.8% | -2.0% | — |
| Cash & Short-Term Equivalents | $133.7M | $103.8M | — |
| Total Debt (Short + Long Term) | $340.7M | $327.7M | — |
| Total Stockholders' Equity | $675.0M | $704.3M | — |